N.A. (submitted trial is a bioequivalence study in healthy human subjects) research hub

Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product Perampanel 2 mg film-coated tablets versus reference product Fycompa 2 mg film-coated tablets (Eisai GmbH) in healthy adult male and female subjects under fasting conditions.

This study checks if a new Perampanel tablet works the same way as the existing Fycompa tablet. Healthy adults take both medicines to see if they deliver the same amount of medicine into the body. This is important to ensure new medicines are just as effective.